In this review:
Promising disease response biomarkers in HL
Defining the early, unfavourable HL subgroup >Target somatic mutations in FL?
Ibrutinib active in ABC subtype of DLBCL
Novel bacterium in cord colitis syndrome
Extended-use apixaban in VTE treatment
Pomalidomide
Please login below to download this issue (PDF)